ARUP Laboratories is a national clinical and anatomic pathology reference laboratory and a worldwide leader in innovative laboratory research and development. Owned by the University of Utah, ARUP offers an extensive test menu of highly complex and unique medical tests. The clinical reference lab performs tens of thousands of tests daily on blood, body fluids, and tissue for clients that include teaching hospitals, hospital groups, clinics, government entities, and other labs across the US. Its test menu includes thousands of assays, ranging from routine screenings (such as allergy and infectious diseases tests) to highly complex genetic and molecular tests.

Catholic Medical Center is a 330-bed hospital serving southern New Hampshire. Services include cancer treatment, surgery, rehabilitation, treatments for sleep disorders, and emergency medical services. Catholic Medical Center includes The Mom's Place, a birthing facility, and the New England Heart Institute. The medical center has partnered with its community to extend health care and dental care to the uninsured and the homeless, and has established a health clinic geared to help refugees being resettled in the area. CMC is planning to affiliate with Dartmouth-Hitchcock Health, which would provide the center with access to a physician network, as well as more specialists, and a teaching hospital.

HeartWare International, Inc., a medical device company, engages in the design, manufacture, and marketing of medical devices for the treatment of advanced heart failure. HeartWare International primarily offers the HeartWare Ventricular Assist System, which includes a left ventricular assist device, or blood pump, patient accessories, and surgical tools designed to provide circulatory support for patients with advanced heart failure. It is also developing the Miniaturized Ventricular Assist Device, a miniaturized device intended for chronic heart failure patients. HeartWare International sells its products in the United States through its clinical trials; and as commercial products to customers in Europe and Australia. HeartWare International is headquartered in Framingham, Massachusetts.

WellGroup HealthPartners provides medical care through a network of health care facilities in the southern suburbs of Chicago. The medical provider operates about a half dozen clinics offering general practice and specialty services. Its more than 80 doctors represent about 25 medical, diagnostic, and surgical specialties, including obstetrics, internal medicine, pulmonary health, orthopedics, endocrinology, and pediatrics. Additional services include rehabilitation therapy, behavioral health, dental, pharmacy, and laboratory offerings. WellGroup HealthPartners is part of the Sisters of St. Francis Health Services.

Hawaii Dental Service company provides dental benefits to more than half a million members throughout the islands and is a not-for-profit affiliate of Delta Dental Plans Association. Hawaii Dental Service provides dental plans to individuals, families, companies, associations, not-for-profit organizations, and unions in a variety of industries. Its network includes nearly all practicing dentists in Hawaii, as well as many in Guam and Saipan. Hawaii Dental Service's membership in Delta Dental provides members with access to tens of thousands of dentists across the US. Hawaii Dental Service company was founded in 1962 by a group of community dentists.

CRH Medical Corporation specializes in the treatment of hemorrhoids utilizing its proprietary CRH O’Regan System which includes CRH’s patented proprietary technology and treatment protocols. CRH’s single use, disposable, hemorrhoid treatment technology is safe and highly effective in treating hemorrhoids. CRH employs two commercialization strategies: firstly, it operates Centers for Colorectal Health facilities (the “Centers”) in the United States specializing in the treatment of hemorrhoids and related anal rectal disorders. The Company currently operates ten Centers geographically dispersed through the U.S. Secondly, CRH distributes its hemorrhoid banding technology, treatment protocols, operational and marketing expertise as a complete, turn key package, directly to its partner physicians, referred to as the “Partnership Program.”

Quotient Bioresearch is a leading provider of early stage and specialist drug development services to pharmaceutical, biotechnology and medical device clients worldwide.Driven by our passion for scientific excellence, our vision is to be recognised as the premier global provider. Our early stage and specialist drug development services are underpinned by a unique combination of medical, chemical and biological expertise. We continually strive to deliver the highest quality service to support our clients’ endeavours in their development of new and pioneering medicines and products.

Timesco of London is a medical supplies company that designs, manufactures, and sells surgical and non-surgical medical and dental instruments. Products are destined for various markets, including emergency healthcare, footcare, laryngyscopy, midwifery, and more. The company uses its own direct sales force in the UK and more than 100 independent agents and distributors to market Timesco's 6,000 different instruments throughout the world. In addition to instruments, Timesco makes medical equipment storage bags, such as the Exmouth delivery bag for midwives.

BioLife Solutions,Inc has designed liquid media technologies for frozen (cryogenic) storage and cold (hypothermic) storage of biological products including cells, tissues, and organs. Its HypoThermosol and CryoStor products minimize the damage done to these biological products during refrigeration and freezing, making them viable for transplant or experimentation for longer periods. The company sells its products directly to academic institutions, companies, and laboratories conducting clinical research.

Spherix Incorporated was launched in 1967 as a scientific research company. The company now leverages its scientific and technical expertise and experience through its two subsidiaries—Biospherics Incorporated and Spherix Consulting, Inc. Biospherics is currently conducting a Phase 3 clinical trial investigating the use of D-Tagatose, a stereoisomer of fructose already approved as a sugar substitute, as a treatment for glycemic control in patients with Type 2 diabetes. Spherix Consulting provides scientific and strategic support for suppliers, manufacturers, distributors and retailers of conventional foods, biotechnology-derived foods, medical foods, infant formulas, food ingredients, dietary supplements, food contact substances, pharmaceuticals, medical devices, consumer products, and industrial chemicals and pesticides.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.